Population PK/PD of propofol and nadroparin in extreme morbidly obese patients
Completed
- Conditions
- Obesitas10017998pharmacokinetics and pharmacodynamics of propofol and nadroparin in morbidly obese patients
- Registration Number
- NL-OMON36134
- Lead Sponsor
- Sint Antonius Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 8
Inclusion Criteria
8 morbidly obese patients a total body weight higher than 170 kg undergoing laparoscopic banding, laparoscopic sleeve gastrectomy or gastric bypass surgery, with a Body Mass Index > 40 kg/m2, 18-60 year old and American Society of Anaesthesiologists (ASA) physical status II to III.
Exclusion Criteria
Epilepsy, pregnancy, breastfeeding and known allergy for propofol, nadroparin, egg lecithin or soy bean oil.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Pharmacokinetic parameters of propofol in patients with a total body weight<br /><br>higher than 170 kg: clearance, intercompartmental clearance, volume of central<br /><br>compartment and volume of peripheral compartment.<br /><br>Pharmacodynamic parameters of nadroparin using anti-Xa levels in patients with<br /><br>a total body weight higher than 170 kg: clearance, intercompartmental<br /><br>clearance, volume of central compartment and volume of peripheral compartment,<br /><br>absorption rate constant, transit rate constant. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Pharmacodynamic parameters of propofol in patients with a total body weight<br /><br>higher than 170 kg; time to induction of anaesthesia (stop counting, eyelash<br /><br>reflex, quality of anaesthesia, corresponding dose required for induction of<br /><br>anaesthesia for both induction doses), EC50 using BIS, required doses of<br /><br>propofol during maintenance of anaesthesia, wake-up time.<br /><br>The occurrence of bleedings or thrombotic events in patients with a total body<br /><br>weight higher than 170 kg.<br /><br>Cardiac output records during surgery, measured by the NICOM® (Cheetah Medical)<br /><br>and Vigileo (Edwards Lifesciences) monitor </p><br>